Streetbeat News

Revenues

HRMY

Harmony Biosciences (NASDAQ:HRMY) has been analyzed by 6 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $52.67, with a high of $56.00 and a low of $52.00. The company has shown strong revenue growth and profitability, but its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

PAYX

In the past three months, analysts have shown varied sentiments towards Paychex (NASDAQ:PAYX), with most ratings being indifferent. The average 12-month price target has increased by 9.57% to $132.8. Analysts from firms like Morgan Stanley and Citigroup have raised their price targets, reflecting a positive outlook. Paychex's financials show strong revenue growth, net margin, and return on equity, indicating robust financial health.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

ZIM

In the past three months, six analysts have provided ratings for ZIM Integrated Shipping (NYSE:ZIM), with a mix of bullish and bearish perspectives. The average 12-month price target is $18.53, slightly down from the previous $18.74. Analysts have adjusted their ratings and price targets, reflecting their views on ZIM's market performance. ZIM has shown strong revenue growth but faces challenges with net margin and debt management.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:00 pm

HAFC

Hanmi Financial (NASDAQ:HAFC) has been analyzed by four analysts, showing a range of perspectives from somewhat bullish to indifferent. The average 12-month price target has increased by 11.69% to $21.5. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Hanmi Financial faces challenges in revenue growth and return on equity but maintains a strong net margin and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:00 pm

LQR

LQR House shares are experiencing an uptick following the announcement of a year-over-year increase in September revenue results.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:50 pm

LQR

LQR House Inc. reported a significant 5700% year-over-year increase in revenue for September 2024, reaching $222,584.72 compared to $3,800 in September 2023.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:48 pm

HUM

Humana Inc. faces a significant decline in its Medicare Advantage Star Ratings for 2025, with only 25% of members in plans rated four stars and above, down from 94% in 2024. This drop, primarily due to contract H5216, will impact quality bonus payments in 2026. Humana is appealing the ratings and working to improve its performance.

Portfolio Pulse from Vandana Singh

October 02, 2024 | 12:48 pm

NEOV

NeoVolta Inc. has secured a $1.4 million deal with National Renewable Energy Partners, expanding its dealer network to new states. This move highlights the growing demand for energy storage solutions in the U.S. as states focus on grid resilience.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:46 pm

STRR

Star Equity Holdings' subsidiary, KBS Builders, has secured two contracts worth $4.6 million to produce modules for cottages and affordable housing in Maine. The projects are expected to be completed by December 2024, with occupancy by Spring 2025.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

KULR

KULR Technology Group has secured a $2.35 million licensing deal with a Japanese corporation for its Xero Vibe technology. The deal includes a $1.1 million guaranteed license fee and potential additional revenue from equipment sales and upgrades.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:32 pm